These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7808967)

  • 21. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.
    Polette M; Nawrocki B; Pintiaux A; Massenat C; Maquoi E; Volders L; Schaaps JP; Birembaut P; Foidart JM
    Lab Invest; 1994 Dec; 71(6):838-46. PubMed ID: 7807965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium.
    Okada Y; Gonoji Y; Nakanishi I; Nagase H; Hayakawa T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(5):305-12. PubMed ID: 1980561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
    Minghetti PP; Blackburn WD
    J Rheumatol; 2000 Mar; 27(3):653-60. PubMed ID: 10743803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
    J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts.
    Aicher WK; Alexander D; Haas C; Kuchen S; Pagenstecher A; Gay S; Peter HH; Eibel H
    Arthritis Rheum; 2003 Feb; 48(2):348-59. PubMed ID: 12571843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.
    Takahashi S; Inoue T; Higaki M; Mizushima Y
    Drugs Exp Clin Res; 1998; 24(2):67-71. PubMed ID: 9675546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromelysin (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase (TIMP-1) mRNA expression in scleritis.
    Girolamo ND; McCluskey PJ; Lloyd A; Wakefield D
    Ocul Immunol Inflamm; 1995; 3(3):181-94. PubMed ID: 22823240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts.
    DiBattista JA; Pelletier JP; Zafarullah M; Iwata K; Martel-Pelletier J
    J Cell Biochem; 1995 Apr; 57(4):619-29. PubMed ID: 7615646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts.
    Ito A; Itoh Y; Sasaguri Y; Morimatsu M; Mori Y
    Arthritis Rheum; 1992 Oct; 35(10):1197-201. PubMed ID: 1418006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts.
    Brinckerhoff CE; Sirum-Connolly KL; Karmilowicz MJ; Auble DT
    Matrix Suppl; 1992; 1():165-75. PubMed ID: 1480018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.
    Cinelli M; Guiducci S; Del Rosso A; Pignone A; Del Rosso M; Fibbi G; Serratì S; Gabrielli A; Giacomelli R; Piccardi N; Matucci Cerinic M
    Scand J Rheumatol; 2006; 35(5):346-50. PubMed ID: 17062432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts.
    Migita K; Eguchi K; Tominaga M; Origuchi T; Kawabe Y; Nagataki S
    Biochem Biophys Res Commun; 1997 Oct; 239(2):621-5. PubMed ID: 9344881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study.
    Young L; Katrib A; Cuello C; Vollmer-Conna U; Bertouch JV; Roberts-Thomson PJ; Ahern MJ; Smith MD; Youssef PP
    Arthritis Rheum; 2001 Feb; 44(2):343-50. PubMed ID: 11229465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
    Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
    Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.